Nissha Co., Ltd.
Notice of Change in Consolidated Subsidiaries (Specific Subsidiaries) Related to Share Transfer
Resolves to transfer 60% of USM shares to Mr. LAM. Transfer decision by the Board of Directors on September 4, 2026; contract signing on the same day; execution planned for mid-September. Post-transfer shareholding will be 0 shares. Background is the discovery of improper accounting at USM. Impact on consolidated financial statements is under investigation.
Key Figures
- Pre-transfer USM share count: 16,960,877 shares
- Transfer percentage: 60% → 0% (to Mr. LAM)
- Date of transfer execution: Mid-September 2026 (planned)
AI要約
Background and Decision
NISSHA acquired 60% of USM and made it a consolidated subsidiary in May 2026, but it was found that improper accounting practices centered on round-tripping occurred prior to the acquisition. Continuing external investigations and finding it difficult to preserve and enhance corporate value, the NISSHA Group decided to transfer the 60% USM stake to Mr. LAM.
Target of Transfer and Share Status
USM HEALTHCARE MEDICAL DEVICES FACTORY JOINT STOCK COMPANY is a medical device manufacturer and distributor based in Ho Chi Minh City, Vietnam. Major shareholders are NISSHA at 59.99%, Mr. LAM at 40.00%, and Nissha Vietnam Co., Ltd. at 0.01%. Before the transfer, the number of shares was 16,960,877; after the transfer, it will be 0.
Nissha Co., Ltd.
Company overview · Stock price · Financial data · All IR
